Technical Analysis for VIRX - Viracta Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.19 | -3.67% | -0.01 |
VIRX closed down 3.67 percent on Friday, November 1, 2024, on 49 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 7
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Doji - Bullish? | Reversal | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% |
| Alert | Time |
|---|---|
| Possible NR7 | about 21 hours ago |
| Rose Above Lower Bollinger Band | 1 day ago |
| Down 5% | 1 day ago |
| Down 3% | 1 day ago |
| Fell Below Previous Day's Low | 1 day ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. It is developing nanatinostat, an oral combination therapy in combination with the antiviral agent valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma. The company was founded in 2007 and is headquartered in Cardiff, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Lymphoma Hematology Antiviral Drug Anatomical Pathology Seagen
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Lymphoma Hematology Antiviral Drug Anatomical Pathology Seagen
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.31 |
| 52 Week Low | 0.19 |
| Average Volume | 882,414 |
| 200-Day Moving Average | 0.58 |
| 50-Day Moving Average | 0.23 |
| 20-Day Moving Average | 0.23 |
| 10-Day Moving Average | 0.23 |
| Average True Range | 0.02 |
| RSI (14) | 33.77 |
| ADX | 20.21 |
| +DI | 20.89 |
| -DI | 20.16 |
| Chandelier Exit (Long, 3 ATRs) | 0.23 |
| Chandelier Exit (Short, 3 ATRs) | 0.25 |
| Upper Bollinger Bands | 0.26 |
| Lower Bollinger Band | 0.20 |
| Percent B (%b) | -0.05 |
| BandWidth | 26.56 |
| MACD Line | -0.01 |
| MACD Signal Line | -0.01 |
| MACD Histogram | -0.0025 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.21 | ||||
| Resistance 3 (R3) | 0.21 | 0.20 | 0.21 | ||
| Resistance 2 (R2) | 0.20 | 0.20 | 0.20 | 0.21 | |
| Resistance 1 (R1) | 0.20 | 0.20 | 0.20 | 0.20 | 0.21 |
| Pivot Point | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 |
| Support 1 (S1) | 0.19 | 0.19 | 0.19 | 0.19 | 0.18 |
| Support 2 (S2) | 0.18 | 0.19 | 0.18 | 0.18 | |
| Support 3 (S3) | 0.18 | 0.18 | 0.18 | ||
| Support 4 (S4) | 0.18 |
